BrainsWay Ltd. (NASDAQ:BWAY) Shares Sold by Good Life Advisors LLC

Good Life Advisors LLC reduced its stake in shares of BrainsWay Ltd. (NASDAQ:BWAY) by 50.0% in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 27,900 shares of the company’s stock after selling 27,900 shares during the period. Good Life Advisors LLC owned about 0.15% of BrainsWay worth $263,000 at the end of the most recent quarter.

Separately, Rhumbline Advisers boosted its holdings in shares of BrainsWay by 10.8% in the 4th quarter. Rhumbline Advisers now owns 21,966 shares of the company’s stock valued at $207,000 after buying an additional 2,144 shares during the period. Institutional investors and hedge funds own 30.11% of the company’s stock.

Analyst Upgrades and Downgrades

Separately, HC Wainwright reaffirmed a “buy” rating and issued a $16.00 price target on shares of BrainsWay in a report on Monday, December 23rd.

BrainsWay Trading Down 4.7 %

BWAY stock opened at $10.75 on Friday. The firm’s 50-day moving average is $10.13 and its two-hundred day moving average is $9.35. The company has a market capitalization of $202.32 million, a price-to-earnings ratio of 107.51 and a beta of 1.25. BrainsWay Ltd. has a 52 week low of $4.61 and a 52 week high of $11.79.

BrainsWay Profile

BrainsWay Ltd. develops and sells noninvasive neurostimulation treatments for mental health disorders in the United States and internationally. It offers Deep Transcranial Magnetic Stimulation platform technology for the treatment of major depressive disorders, anxious depression, obsessive-compulsive disorders, smoking addiction, bipolar disorders, post traumatic stress disorders, schizophrenia, Alzheimer's disease, autism, chronic pain, multiple sclerosis, post stroke rehabilitation, and Parkinson's diseases.